Scaling Biotech Real Estate: 5 Common Lab Space Mistakes Early-Stage Life Sciences Companies Make
For many early-stage life sciences companies, securing their first lab space is an exciting milestone. However, the transition from an incubator or shared research environment into dedicated lab space is often one of the most complex operational decisions a founder will make.
Unlike a traditional office move, scaling a life sciences company requires careful coordination of specialized infrastructure, permitting, equipment, utilities, and long-term growth planning. Whether preparing for commercialization or biomanufacturing, real estate decisions can directly affect hiring timelines, research continuity, regulatory compliance, and future fundraising. Companies that approach real estate as a strategic business decision, rather than a last-minute operational need, are far better positioned to earn the continued support of their financial stakeholders and scale successfully.
At Labspace Directory, one question founders repeatedly ask is: “How can we avoid making an expensive real estate mistake as we grow?” The answer starts with understanding where many life science startups encounter challenges and how to plan ahead before those challenges become costly.
Mistake #1: Waiting Too Long to Start Planning
One of the biggest mistakes early-stage biotech founders make is underestimating how long the real estate process actually takes.
Fundraising, research milestones, key hires, and product development naturally demand most of a leadership team's attention. As a result, facility planning is often delayed until the existing facility no longer supports the company's growth. By then, temporary expansion space becomes reactive and off-budget, timelines become compressed, negotiating leverage decreases, critical long-lead items may be unavailable, and space options may be more limited.
For companies anticipating growth into new space, planning should begin well before occupancy. In fact, Labspace Directory's Life Sciences Move-In & Move-Out Checklist recommends beginning the process at least 12 months before move-in, starting with resourcing the move with subject matter experts, programming, identifying target submarkets, engaging a real estate advisor, and understanding permitting requirements before touring properties.
Companies that begin planning early maintain flexibility and leverage. Those that wait often find themselves reacting to immediate space constraints instead of making strategic decisions that support long-term growth.
Mistake #2: Searching for Lab Space Before Defining Your Requirements
Many founders begin touring available lab space before fully understanding what their company actually needs. Before evaluating properties, companies should complete what is known as the programming phase: the process of identifying the scientific, operational, demographic, and technical requirements that will shape their real estate search. This is where many companies either set themselves up for success or create future challenges.
Life science facilities are purpose-built environments designed to support specialized research and manufacturing activities. Wet labs, dry labs, cleanrooms, and biomanufacturing facilities all require different infrastructure, utility capacity, ventilation systems, hazardous material storage, and operational workflows.
Before beginning a property search, founders should first define:
Current and projected staffing needs
Laboratory workflows
Equipment dimensions and floor loading requirements
Utility and HVAC demands
Hazardous materials storage and disposal requirements
Cleanroom or manufacturing needs
Future expansion plans and flexibility
Contingency planning for downsizing or lease termination
The more clearly defined these requirements are, the more effective the programming and site selection process becomes.
Mistake #3: Overlooking Permitting and Infrastructure
Many first-time founders assume that if a laboratory building is available, it can accommodate their scientific operations. In reality, permitting, entitlements, and infrastructure constraints often become the biggest sources of project delays.
Certain municipalities place restrictions on hazardous materials usage, animal testing, manufacturing activities, operating hours, or future expansion. At the same time, not every laboratory building has sufficient electrical capacity, standby emergency power, robust HVAC systems, utility infrastructure, or rigorous operating standards to support specialized life sciences operations. In some markets, utility upgrades alone can delay occupancy from several months to several years vastly increasing project costs.
Understanding these requirements before signing a lease helps companies avoid costly surprises and keeps expansion timelines and budgets on track.
Mistake #4: Staying Too Long in Incubator Space
Incubators play an essential role in helping early-stage companies launch. They offer quick availability, flexibility, shared resources, and lower barriers to entry.
However, many successful startups remain in incubator environments longer than necessary because relocating is perceived as too disruptive to an early-stage company.
As scientific programs mature and teams expand, shared facilities begin hindering productivity while occupancy costs continue to rise. Dedicated lab space often provides greater efficiency, improved workflow, and lower long-term occupancy costs than remaining in shared environments.
Knowing when to transition into dedicated space can be just as important as choosing the right location.
Mistake #5: Treating Real Estate as a Transaction Instead of a Growth Strategy
The most successful biotech founders recognize that real estate is about much more than finding available space. Every facility decision influences hiring, production capacity, research continuity, regulatory compliance, meeting milestones, investor confidence, and future fundraising. As companies move from research and development toward commercialization, their real estate strategy becomes increasingly intertwined with their overall business strategy.
As Labspace Directory co-founders David Klein, Esq. CCIM SIOR LEED AP MCR and Elijah (E.J.) Hodges often advise their clients, successful scaling requires balancing real estate, labor, infrastructure, capital planning, realistic scheduling, and long-term operational goals rather than treating each decision independently.
The Opportunity in Today's Market
Today's life sciences real estate market presents opportunities that many early-stage companies haven't seen in years. As discussed in our 2026 Mid-Year Life Sciences Real Estate Outlook, increased availability is giving founders more flexibility and negotiating leverage than they had during the market's peak.
Rather than settling for the first available lab space, founders have an opportunity to evaluate multiple facilities, negotiate more favorable lease terms, and identify spaces that better support long-term growth.
Companies that begin planning early, define their facility requirements, and assemble the right team of advisors will be well positioned to capitalize on today's market while avoiding many of the costly mistakes that delay growth.
Whether you're evaluating your first dedicated lab space or preparing for your next expansion, Labspace Directory provides available lab space listings, localized market intelligence, and practical planning resources to support every stage of your real estate journey. For additional guidance, explore our Life Sciences Move-In & Move-Out Checklist, which outlines a recommended 12-month timeline for planning a successful laboratory relocation. Connect with our team to start building a real estate strategy that supports your next stage of growth.